Bumper Offer - Urjas oil Just @ Rs. 1
Eurepa 1 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of Diabetes Type 2.
The correct dosage of Eurepa 1 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. This information has been provided in detail in the dosage section.
While these are the most often observed Eurepa 1 Tablet side effects, there are can be others also. These have been listed below. Usually, these side effects of Eurepa 1 Tablet go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
Eurepa 1 Tablet's effect during pregnancy is Severe and Severe while nursing. It is important to know if Eurepa 1 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Eurepa 1 Tablet related warnings section.
Eurepa 1 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetic Ketoacidosis, Diabetes Type 1, Heart Disease are examples of such conditions. Some other conditions that can be affected by Eurepa 1 Tablet are listed in the contraindications section below.
Drug interactions for Eurepa 1 Tablet have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Eurepa 1 Tablet, it is important to know that it is safe while driving, and is habit-forming.
Eurepa 1 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Eurepa 1 Tablet is used -
Severe
Moderate
Mild
Is the use of Eurepa 1 Tablet safe for pregnant women?
Eurepa should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Eurepa 1 Tablet safe during breastfeeding?
Eurepa may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Eurepa 1 Tablet on the Kidneys?
There can be some harmful effects on your kidneys after taking Eurepa. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Eurepa 1 Tablet on the Liver?
Eurepa can have moderate side effects on the liver. If you notice any harmful effects then stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Eurepa 1 Tablet on the Heart?
Eurepa is rarely harmful for the heart.
Eurepa 1 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Eurepa 1 Tablet unless your doctor advises you to do so -
Is this Eurepa 1 Tablet habit forming or addictive?
Eurepa 1 Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Eurepa 1 Tablet since it will not make you feel sleepy.
Is it safe?
Yes, Eurepa 1 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Eurepa 1 Tablet for mental disorders.
Interaction between Food and Eurepa 1 Tablet
Due to the absence of research, it is difficult to say how Eurepa 1 Tablet and food will interact.
Interaction between Alcohol and Eurepa 1 Tablet
Taking alcohol with Eurepa 1 Tablet can be dangerous.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Prandin® (repaglinide)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 273